Autolus Therapeutics plc (AUTL) › Cost of RevenueAutolus Therapeutics plc (AUTL) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2023: $02024: $11.39M2025: $96.37M$96.37M2023Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$96.37M+746.3%2024$11.39M—2023$0—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share